Table 1.

Correlation between expression of RBFOX2 and inclusion of exons in RBFOX2 target genes

	MALT1 exon 7		CLSTN1 exon 11		FMNL3 exon 26		MYO9B exon 37
	Correlation	p-value	Correlation	p-value	Correlation	p-value	Correlation	p-value
DLBCL ABC (n = 26)	0.496	0.009	0.450	0.023	0.139	0.496	0.338	0.09
DLBCL GCB (n = 37)	0.591	0.0001	0.147	0.383	0.558	0.0004	0.561	0.0003
DLBCL type III (n = 15)	0.125	0.675	0.385	0.156	1	0	0.307	0.265
All DLBCL (n = 78)	0.522	1.2 x 10−6	0.303	0.007	0.300	0.008	0.566	1.1 x 10−7
BL (solid ped BL) (n = 21)	0.703	0.0005	0.669	0.001	0.484	0.027	0.672	0.001
FL (n = 87)	0.321	0.003	0.437	2.3 x 10−5	0.227	0.034	0.397	0.0001
FL-DLBCL (n = 15)	0.464	0.083	0.029	0.923	0.503	0.058	0.435	0.106
GC B cells, control (n = 5)	−0.9	0.083	0.2	0.783	0.3	0.683	−0.2	0.783
Naive B cells, control (n = 5)	0.6	0.083	-0.354	0.783	-0.8	0.683	−0.2	0.783

RNASeq data from lymphoma and control, mapped to hg38 with segemehl 2.0; data were normalized against target

gene expression. Bold: statistically significant. Normalization: transformation to target gene expression levels